COMMERCIAL FILL/FINISH SERVICES AGREEMENTFinish Services Agreement • January 18th, 2019 • Avedro Inc • Pharmaceutical preparations • New York
This COMMERCIAL FILL/FINISH SERVICES AGREEMENT (the “Agreement”) is entered into as of the 19th day of December, 2014 (“Effective Date”) by and between AVEDRO, Inc. (“Clients”), and AJINOMOTO ALTHEA, INC., a Delaware corporation, with a place of business located at 11040 Roselle Street, San Diego, CA 92121 (“Althea”);
AMENDMENT NO. 1 TO THE TECHNOLOGY TRANSFER, VALIDATION AND COMMERCIAL FILL/FINISH SERVICES AGREEMENTFinish Services Agreement • February 25th, 2021 • Revance Therapeutics, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 1 (this “Amendment”) is made and entered into as of December 18th, 2020 (the “Amendment Effective Date”), by and between Revance Therapeutics, Inc., (“Client”), and Ajinomoto Althea, Inc., dba Aji Bio-Pharma Services (“ABPS”).
AMENDMENT NO. 2 TO THE TECHNOLOGY TRANSFER, VALIDATION AND COMMERCIAL FILL/FINISH SERVICES AGREEMENTFinish Services Agreement • February 28th, 2024 • Revance Therapeutics, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 2 (this “Amendment”) is made and entered into as of February 23, 2024 (the “Amendment Effective Date”), by and between Revance Therapeutics, Inc., (“Client”), and Ajinomoto Althea, Inc., dba Ajinomoto Bio-Pharma Services, a California (formerly Delaware) corporation (“ABPS”).
